These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33177256)

  • 1. [Colitis-associated cancer in ulcerative colitis -pathological condition and chemoprevention].
    Kusunoki R; Kuwai T; Ishihara S
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(11):947-956. PubMed ID: 33177256
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.
    Allgayer H; Kruis W
    Clin Gastroenterol Hepatol; 2006 Apr; 4(4):521; author reply 521. PubMed ID: 16616360
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemoprevention: a new way to face colorectal cancer in ulcerative colitis.
    Biasco G; Zannoni U
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):426-7. PubMed ID: 9789143
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemoprevention of colorectal cancer in ulcerative colitis.
    Thomson A
    Intern Med J; 2006 Aug; 36(8):540; author reply 541. PubMed ID: 16866668
    [No Abstract]   [Full Text] [Related]  

  • 5. [Colitis-associated colorectal cancer in ulcerative colitis - current status and problems of surgical treatment].
    Ikeuchi H; Uchino M
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(11):965-970. PubMed ID: 33177258
    [No Abstract]   [Full Text] [Related]  

  • 6. [Colorectal cancer in ulcerative colitis].
    Laugesen KB; Tøttrup A
    Ugeskr Laeger; 2014 Jan; 176(4A):V07130441. PubMed ID: 25347248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of chemoprevention of colorectal cancer with 5-aminosalicylates in ulcerative colitis.
    Herfarth H
    Dig Dis; 2012; 30 Suppl 2():55-9. PubMed ID: 23207933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid and sulfasalazine for colorectal carcinoma chemoprevention in patients with ulcerative colitis: the old and new evidence.
    Diculescu M; Ciocîrlan M; Ciocîrlan M; Piţigoi D; Becheanu G; Croitoru A; Spanache S
    Rom J Gastroenterol; 2003 Dec; 12(4):283-6. PubMed ID: 14726972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of colorectal cancer in ulcerative colitis: digging deep in current evidence.
    Bezzio C; Festa S; Saibeni S; Papi C
    Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):339-347. PubMed ID: 28165825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colitis-associated cancer in ulcerative colitis -current status and problems for diagnosis].
    Naganuma M
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(11):939-946. PubMed ID: 33177255
    [No Abstract]   [Full Text] [Related]  

  • 11. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
    Lindberg BU; Broomé U; Persson B
    Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical review of the evidence on 5-aminosalicilate for chemoprevention of colorectal cancer in ulcerative colitis: a methodological question.
    Margagnoni G; Pagnini C; Menasci F; Festa S; Delle Fave G
    Curr Clin Pharmacol; 2014 Feb; 9(1):84-90. PubMed ID: 24218994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoprevention of colorectal cancer in ulcerative colitis.
    Croog VJ; Ullman TA; Itzkowitz SH
    Int J Colorectal Dis; 2003 Sep; 18(5):392-400. PubMed ID: 12904996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: colitis-associated cancer -- time for new strategies.
    Shanahan F
    Aliment Pharmacol Ther; 2003 Sep; 18 Suppl 2():6-9. PubMed ID: 12950414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcerative colitis-associated colorectal cancer.
    Yashiro M
    World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer prevention in patients with ulcerative colitis.
    Lopez A; Pouillon L; Beaugerie L; Danese S; Peyrin-Biroulet L
    Best Pract Res Clin Gastroenterol; 2018; 32-33():103-109. PubMed ID: 30060933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of therapy with 5-aminosalicylic acid in chemoprevention of colorectal carcinoma in ulcerative colitis].
    Herfarth H; Schölmerich J
    Z Gastroenterol; 2000 Nov; 38(11):923-5. PubMed ID: 11132541
    [No Abstract]   [Full Text] [Related]  

  • 18. [Colitis cancer--myth or reality?].
    Hertervig E; Befrits R; Ekbom A; Karlén P; Lindberg J; Löfberg R; Rutegård J; Sjöqvist U; Ost A
    Lakartidningen; 2009 Nov 4-12; 106(45):3000-2. PubMed ID: 19998826
    [No Abstract]   [Full Text] [Related]  

  • 19. Should we sound the alarm? Dysplasia and colitis-associated colorectal cancer.
    Ren LL; Fang JY
    Asian Pac J Cancer Prev; 2011; 12(8):1881-6. PubMed ID: 22292619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mesalazine in ulcerative colitis. Fewer cases of colorectal carcinoma].
    MMW Fortschr Med; 2002 Feb; 144(9):51. PubMed ID: 11921656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.